Haojun Yang

68 GeHu Road
Changzhou, 213000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Helicobacter pylori-induced ADAMDEC1 overexpression in M2 macrophages drives preneoplastic progression in the gastric mucosa.

Helicobacter pylori-induced ADAMDEC1 overexpression in M2 macrophages drives preneoplastic progression in the gastric mucosa.

Journal: Journal of biomedical research

Published: May 27, 2026

ALKBH5 promotes gastric cancer angiogenesis by stabilizing LncRNA PVT1 and VEGFA RNAs via m6A demethylation.

ALKBH5 promotes gastric cancer angiogenesis by stabilizing LncRNA PVT1 and VEGFA RNAs via m6A demethylation.

Journal: Molecular and cellular biochemistry

Published: September 23, 2025

Prognostic Significance and Immune Environment Analysis Using PANoptosis Molecular Clustering in Gastric Cancer.

Prognostic Significance and Immune Environment Analysis Using PANoptosis Molecular Clustering in Gastric Cancer.

Journal: Medical science monitor : international medical journal of experimental and clinical research

Published: May 03, 2025

Clinicopathological features and prognosis of alpha-fetoprotein-producing colorectal adenocarcinoma.

Clinicopathological features and prognosis of alpha-fetoprotein-producing colorectal adenocarcinoma.

Journal: Histopathology

Published: July 07, 2024

Targeting TGR5 to mitigate liver fibrosis: Inhibition of hepatic stellate cell activation through modulation of mitochondrial fission.

Targeting TGR5 to mitigate liver fibrosis: Inhibition of hepatic stellate cell activation through modulation of mitochondrial fission.

Journal: International immunopharmacology

Published: May 08, 2024

YTHDF1 mediates N-methyl-N-nitrosourea-induced gastric carcinogenesis by controlling HSPH1 translation.

YTHDF1 mediates N-methyl-N-nitrosourea-induced gastric carcinogenesis by controlling HSPH1 translation.

Journal: Cell proliferation

Published: October 06, 2023

Immunotherapy and targeted therapy as first-line treatment for advanced gastric cancer.

Immunotherapy and targeted therapy as first-line treatment for advanced gastric cancer.

Journal: Critical reviews in oncology/hematology

Published: June 01, 2023

Screening of Biomarkers in Liver Tissue after Bariatric Surgery Based on WGCNA and SVM-RFE Algorithms.

Screening of Biomarkers in Liver Tissue after Bariatric Surgery Based on WGCNA and SVM-RFE Algorithms.

Journal: Disease markers

Published: November 14, 2022

circSMAD4 Promotes Experimental Colitis and Impairs Intestinal Barrier Functions by Targeting Janus Kinase 2 Through Sponging miR-135a-5p.

circSMAD4 Promotes Experimental Colitis and Impairs Intestinal Barrier Functions by Targeting Janus Kinase 2 Through Sponging miR-135a-5p.

Journal: Journal of Crohn's & colitis

Published: October 14, 2022

Correction: PLGA-microspheres-carried circGMCL1 protects against Crohn's colitis through alleviating NLRP3 inflammasome-induced pyroptosis by promoting autophagy.

Correction: PLGA-microspheres-carried circGMCL1 protects against Crohn's colitis through alleviating NLRP3 inflammasome-induced pyroptosis by promoting autophagy.

Journal: Cell death & disease

Published: September 19, 2022

PLGA-microspheres-carried circGMCL1 protects against Crohn's colitis through alleviating NLRP3 inflammasome-induced pyroptosis by promoting autophagy.

PLGA-microspheres-carried circGMCL1 protects against Crohn's colitis through alleviating NLRP3 inflammasome-induced pyroptosis by promoting autophagy.

Journal: Cell death & disease

Published: June 03, 2022

Impacts of bariatric surgery on adverse liver outcomes: a systematic review and meta-analysis.

Impacts of bariatric surgery on adverse liver outcomes: a systematic review and meta-analysis.

Journal: Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery

Published: June 02, 2022

Showing 1-12 of 35

Last Updated: 09/26/2026